Clinical trial · Observational
Role of MRI Breast in Detection of Ductal Carcinoma in Situ
NCT06744140CI-TRIAL-00083958active not recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
"This study investigates the role of Magnetic Resonance Imaging (MRI) in detecting Ductal Carcinoma in situ (DCIS) in high-risk breast cancer patients.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Carcinoma in Situ | Carcinoma In Situ | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Magnetic Resonance Imaging (MRI) | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (2)
- measure
- sensitivity & specificity
- timeFrame
- 12 Months
- description
- sensitivity \& specificity of MRI in detecting DCIS
- measure
- BIRADS scores
- timeFrame
- 12 Months
- description
- BIRADS scores will be used to evaluate the diagnostic accuracy of MRI in detecting DCIS
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 30 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: * High-risk breast cancer patients with a family history of breast cancer or genetic predispositions (e.g., BRCA mutations). * Patients aged 30-65 years. * Patients willing to undergo breast MRI screening for DCIS detection. Exclusion Criteria: * Patients with contraindications to MRI imaging (e.g., pacemakers, claustrophobia). * Patients with a history of prior breast surgery or interventions that may interfere with imaging interpretation.
References
Publications (0)
Data not yet available
No reference posted for this study.